A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (=16 years) low grade glioma - A final report

of THE Low Grade Glioma Consortium And Participating Centers

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (=16 years) low grade glioma - A final report

of THE Low Grade Glioma Consortium And Participating Centers

Research output: Contribution to journal › Article › Scientific › peer-review

115 Citations (Scopus)

Original language	English
Pages (from-to)	206-225
Journal	EUROPEAN JOURNAL OF CANCER
Volume	81
Publication status	Published - 2017
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 1

Access to Document

https://pubmed.ncbi.nlm.nih.gov/28649001

Cite this

of THE Low Grade Glioma Consortium And Participating Centers (2017). A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (=16 years) low grade glioma - A final report. EUROPEAN JOURNAL OF CANCER, 81, 206-225. https://pubmed.ncbi.nlm.nih.gov/28649001

@article{3156adcb6b8f420a9635023325f80b8e,

title = "A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (=16 years) low grade glioma - A final report",

author = "{of THE Low Grade Glioma Consortium And Participating Centers} and AK Gnekow and DA Walker and D Kandels and M Arola",

year = "2017",

language = "English",

volume = "81",

pages = "206--225",

journal = "EUROPEAN JOURNAL OF CANCER",

issn = "0959-8049",

publisher = "Elsevier",

}

of THE Low Grade Glioma Consortium And Participating Centers 2017, 'A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (=16 years) low grade glioma - A final report', EUROPEAN JOURNAL OF CANCER, vol. 81, pp. 206-225. <https://pubmed.ncbi.nlm.nih.gov/28649001>

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (=16 years) low grade glioma - A final report. / of THE Low Grade Glioma Consortium And Participating Centers.
In: EUROPEAN JOURNAL OF CANCER, Vol. 81, 2017, p. 206-225.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (=16 years) low grade glioma - A final report

AU - of THE Low Grade Glioma Consortium And Participating Centers

AU - Gnekow, AK

AU - Walker, DA

AU - Kandels, D

AU - Arola, M

PY - 2017

Y1 - 2017

M3 - Article

SN - 0959-8049

VL - 81

SP - 206

EP - 225

JO - EUROPEAN JOURNAL OF CANCER

JF - EUROPEAN JOURNAL OF CANCER

ER -